Chronic heart failure (CHF) is one of the most common causes of death in Western countries. The aim of this study was to establish and validate a model of CHF in the rat. This rat model should result in parameters and symptoms that can be extrapolated to the clinical situation of patients with end-stage heart failure. At present only palliative therapy is possible for patients with heart failure but the aim for the future is to nd a causal therapy of heart failure treatment. The rat model should be a valuable method for the early testing of new therapeutic approaches in patients with congestive heart failure.
Animals and methods
Housing/animal care Adult male 4-month-old SHR/NHsd and WKY/NHsd rats (Harlan Sprague Dawley, Winkelmann, Germany) weighing 250-300 g were used at the beginning of the experiments. The health certi cate, which was delivered with the rats, indicated that they were free of the microorganisms monitored according to FELASA. The rats underwent an acclimatization period of 4 weeks prior to the onset of the experiment. The animals were housed in groups of three in Makrolon IV cages with softwood bedding (Lignocel ® , Rettenmaier & Söhne, Ellwangen-Holzmühle, Germany) for the duration of the experiment. The room temperature was maintained at 21 6 18 C and the room air was exchanged 10-15 times per hour. The room lighting was set to a 12 h light/dark cycle. The rats were fed with a standard rat maintenance diet (Altromin, Maintenance Diet 1320, sodium content 0.2%) and had access to drinking water ad libitum.
Study design
Four-month-old WKY/NHsd and SHR/NHsd rats were randomized into two groups-sham and myocardial infarction (MI). The sham procedure consisted of opening the pericardium and a super cial suture in the epicardium of the left ventricle (LV). CHF was induced by permanent (8 weeks) occlusion of the left coronary artery 2 mm distal to the origin from the aorta resulting in a large infarction of the free left ventricular wall.
Eight weeks after surgery, parameters indicating CHF were measured. Cardiac hypertrophy, function and geometric properties were determined by the 'working heart' mode and in vivo determinations by MRI and heart weight. Hydroxyproline/proline ratio was measured as an indicator of heart brosis. The body weight of each animal was taken weekly. Cages were inspected daily for clinical signs of CHF in rats. Rats were excluded from the study and euthanized when they show severe symptoms of cardiac failure, could not lie down because of severe dyspnoea, stopped grooming behaviour, became immobile and lost 15% body weight. These animals were included in the estimation of procedure-related mortality rates. Rats that died of unexpected causes and with no MI were excluded from the mortality measurements directly associated with the procedure.
Surgery
The rats were anaesthetized with a mixture of ketamine/xylazine (35/2 mg/kg i.p., Ketamin 10% ® , WDT, Garbsen, Germany, Rompun, Bayer, Germany). The left ventrolateral thorax was shaved and prepared to create a disinfected surgical access area. When a stable anaesthesia was achieved the animals were placed on a small animal operation table, intubated and ventilated with room air using a small animal ventilator (KTR-4, Hugo Sachs Elektronik, March-Hugstedten, Germany). The level of anaesthesia was deemed as adequate following loss of the pedal withdrawal re ex and absence of the palpebral re ex. Re exes were evaluated before surgery. The operation took 5 min. The tidal volume was adjusted at 3-5 ml and the ventilation rate was 40 breaths/min. Left thoracotomy was performed via the third intercostal space. The heart was exposed and the pericardium opened. The left main coronary artery was ligated with Perma-Hand ® silk 4-0 USP (Ethicon, Nordersredt, Germany) near its origin at the aorta (2 mm distal to the edge of the left atrium). Ligation resulted in infarction of the free left ventricular wall. Ligation was deemed successful when the anterior wall of the left ventricle turned pale. At this point the lungs were hyperin ated by increasing the positive endexpiratory pressure, and the chest was closed. The rats were placed on a heating pad and covered with a layer of unbleached tissue paper. The rats were extubated following return of re exes. They were continuously monitored until they start moving in their cages. To avoid ventricular arrhythmias, lidocain (Xylocaine ® , 2 mg/kg i.m, Astra Zeneca, Germany) was given before surgery. The sham procedure consisted of opening the pericardium and placing a super cial suture in the epicardium of the LV. To prevent acute lung oedema, the rats received furosemide (Lasix ® , 2 mg/kg body weight twice daily for 3 days, Aventis Pharma, Germany) via the drinking water.
To avoid pain and distress the rats received metamizol treatment (Novalgin ® , 0.1 mg/kg body weight i.m., Aventis Pharma, Germany) once, directly after the recovery period. All surgical interventions were carried out under aseptic conditions. All experiments were performed in accordance with the German Animal Protection Law.
Measurements at the end of the study
Before killing the animals 8 weeks after MI, non-invasive sequential nuclear magnetic resonance (NMR) measurements of heart geometric properties were done. Thereafter the animals were anaesthetized with pentobarbitone (180 mg/kg i.p. Pentobarbital ® (Sigma Chemicals, München, Germany)) and subsequently heparinized (Heparin Natrium 25000 IE Inj. Lsg. ® , Albrecht, Germany; 500 I.U./100 g body weight i.p.). Once stable anaesthesia was achieved (stage III 3, re exes absent), the animals were connected to an arti cial respirator via a PE (polyethylene) tube inserted into the trachea and ventilated with room air. The right carotid artery was cannulated with a polyethylene catheter to monitor and accord mean blood pressure, systolic blood pressure, diastolic blood pressure and heart rate over a stable time course of 10 min. A transverse laparatomy and a right anterolateral thoractomy were performed, and the heart was rapidly removed for the evaluation of its function in the working heart mode. Thereafter the heart weight, and the left and right ventricular weights were determined. For infarct size determination the left ventricle was sectioned transversely into four slices from the apex to the base. The infarct size was determined by planimetry and expressed as a percentage of LV mass. Lung weight and further lung histology sections were evaluated. Hydroxyproline/proline ratio was determined in paraf n embedded slices of the left ventricle.
Magnetic resonance imaging
The animals were monitored by MRI at Day 7 and Day 42 post-MI. The animals were anaesthetized with a mixture of 1% halothane (Halothane ® , Hoechst, Frankfurt, Germany) and 30/70 N 2 O/oxygen (N 2 O, oxygen Messer Griesheim, Frankfurt, Germany) with a specially manufactured rat mask. The fully anaesthetized rats (phase III 3) were placed on a cradle made of plexiglas in a supine position. Respiration and ECG were monitored continuously. MRI experiments were performed as described earlier (Rudin et al. 1991) . The images were acquired by a spinecho sequence SE (500/20), the eld of view was 50 mm, the image resolution was 256 3 256 pixels with a dimension of 0.2 3 0.2 mm. Four adjacent transverse slices were recorded; slice thickness was 1.5 mm. Before the acquisition of data, a coronary pilot scan was measured for adequate positioning of the transverse slices. MRI data acquisition was gated to the cardiac cycle by a Physiograd SM 785 MR monitoring system (Bruker, Karlsruhe, Germany) as previously described (Rudin et al. 1991) . Two sets of transverse images were acquired, one at end-systole and another at end-diastole. End-diastole was de ned as the image obtained 8 ms after the onset of the R wave of the ECG, corresponding to the largest cavity area. End-diastole was de ned as the image with the smallest LV cavity area. The image analysis was done using Bruker software (Karlsruhe, Germany). The parameters of left ventricular end diastolic volume (LVEDV), left ventricular end systolic volume (LVESV), septum size, infarct size, ejection fraction (EF), left ventricular chamber diameter (r) and circumference were measured. EF was estimated in percentage terms by the subtraction of LVEDV-LVESV. After the procedure the rats were ventilated with oxygen, the mask was replaced, and they were brought back into their cages where they were covered with a layer of bleached tissue paper to keep them warm. They were monitored until they started moving in the cage.
Blood pressure/heart rate
The animals were anaesthetized with pentobarbitone (180 mg/kg i.p. Pentobarbital
Laboratory Animals (2004) 38 (Sigma Chemicals, München)) and subsequently heparinized (Heparin Natrium 25000 IE Inj. Lsg. ® , Albrecht, Germany; 500 I.U./100 g body weight i.p.). Once stable anaesthesia was achieved, the animals were connected to an arti cial respirator via a PE tube inserted into the trachea and ventilated with room air. The right carotid artery was cannulated with a polyethylene catheter. The catheter was connected to a PLUGSYSmeasuring system (Hugo Sachs Elektronik, March-Hugstedten, Germany) to monitor and accord mean blood pressure, systolic blood pressure, diastolic blood pressure and heart rate over a stable time course of 10 min.
Working heart
For the nal investigations, the heart of the anaesthetized rat was rapidly removed and immersed in physiological buffer chilled to 48 C. The aorta was dissected free and mounted onto a cannula (internal diameter: 1.4 mm) attached to a perfusion apparatus. The hearts were perfused according to the method of Langendorff (LH) with an oxygenated (95% O 2 /5% CO 2 ) non-circulating Krebs-Henseleit solution of the following compositions (mmol/l): NaCl, 118; KCl, 4.7; CaCl 2 , 2.52; MgSO 4 , 1.64; NaHCO 3 , 24.88; KH 2 PO 4 , 1.18; glucose, 5.55; and Napyruvate, 2.0 at a perfusion pressure of 60 mmHg. Any connective tissue, thymus or lung was carefully removed. A catheter placed into the pulmonary artery drained the coronary ef uent perfusate that was collected for the determination of coronary ow and venous pO 2 measurements. The left atrium was cannulated via an incision of the left auricle. All pulmonary veins were ligated close to the surface of the atria. When a tight seal with no leaks had been established and after a 15 min equilibration period, the hearts were switched into the working mode, using a lling pressure (preload) of 12 mmHg in WKY/NHsd and 18 mmHg in SH rats. The afterload pressure was 60 mmHg in WKY/NHsd and 80 mmHg in SH rats. After validation of the basis parameters the afterload pressure was enhanced in a cumulative manner from an additional 20 mmHg to 140 mmHg.
Thereafter the isovolumetric maxima were determined by enhancing the preload pressure in steps of 5 mmHg to 30 mmHg.
Flow and pressure signals for computation were obtained from the PLUGSYS-measuring system (Hugo Sachs Elektronik, March-Hugstedten, Germany). Computation of data was performed with a sampling rate of 500 Hz, averaged every 2 s, using the software Aquire Plus V1.21f (PO-NE-MAH, Hugo Sachs Elektronik, March-Hugstedten, Germany).
Determination of infarct size
After the evaluation of the external heart work, the total heart weight, the left and right ventricular weights were determined. The left ventricle was then sectioned transversely into four slices from the apex to the base. Eight pictures were taken of each rat heart, two from each slice. Total infarct size was determined by planimetry of the projected and magni ed slices. The area of infarcted tissue as well as the intact myocardium of each slice were added together and averaged. The infarcted fraction of the left ventricle was calculated from these measurements and expressed as a percentage of the LV mass. The left ventricular perimeter, diameter, infarct scar length, as well as wall thickness and infarct wall thinning, were determined as well. According to Pfeffer et al. (1985) and , rats with infarct sizes , 20% and . 40% were excluded from the study.
Lung histological determination
After lung weight determination, the organ was immersed in 4% formalin (pH 7.0-7.5; 0.1 M). The lung was cut into small pieces, dehydrated and embedded in paraf n. Haematoxylin & eosin (HE) sections were evaluated by light microscopy (Olympus BX 40, Olympus, Hamburg, Germany).
Hydroxyproline/proline ratio
After embedding, the rest of the xed left ventricular tissue was freeze-dried. Proline and hydroxyproline was then analysed according to the method of López de León and Rojkind (1985) and the ratio of both were calculated.
Statistical analysis
The data are given as mean 6 SEM. Statistics were performed using the SAS system statistics package (SAS Insititute Inc, Cary, NC, USA) with a sequential rejection t-test according to Holm (Cary 1989 ).
Results

Infarct size
There was no signi cant difference between the infarct size of the Wistar and spontaneously hypertensive rats (WKY/NHsd infarct: 24.33 6 1.71% vs SHR/NHsd infarct: 28.28 6 1.32%) (Fig 1) . For the comparison of these groups, the moderate infarcts IS (infarct size) . 20, , 40 (Pfeffer et al. 1985 were selected.
Working heart
Eight weeks after experimental MI, contractility (dP/dt max ) was signi cantly decreased in the infarcted WKY/NHsd rats (infarct: 2.47 6 0.21 mmHg/s vs sham: 3.59 6 0.24 mmHg/s) and in the infarcted SHR/NHsd rats (infarct: 3.67 6 0.31 mmHg/s vs sham: 4.86 6 0.16 mmHg/s). Thus contractility (dP/dt max ) was signi cantly increased in SHR/NHsd (4.86 6 0.16 mmHg/s) as compared with WKY/NHsd sham rats (3.59 6 0.24 mmHg/s) (Fig 2) . Aortic ow index was slightly, but not signi cantly reduced in infarcted WKY/NHsd (infarct: 3.67 6 0.31ml minxg vs sham: 4.86 6 0.16 ml minxg ). In the infarcted SHR/NHsd rats, the aortic ow index was signi cantly reduced, as compared with the sham animals (infarct: 3.67 6 0.31 ml minxg vs sham: 4.86 6 0.16 ml minxg ) (Fig 3) . Blood pressure/heart rate The mean blood pressure of the infarcted animals was slightly reduced in the infarcted WKY/NHsd rats (infarct: 72 6 2 mmHg vs sham: 82 6 6 mmHg) and signi cantly in the infarcted SHR/NHsd rats (infarct: 100 6 6 mmHg vs sham: 124 6 8 mmHg). In comparison to the WKY/NHsd rats, the mean blood pressure is enhanced in the SHR/NHsd rats (WKY/NHsd sham: 82 6 6 mmHg vs SHR/NHsd sham: 124 6 8 mmHg) (Fig 4) . The heart rate remained unaltered in the WKY/NHsd rats (infarct: 351 6 14 beats/min vs sham: 344 6 8 beats/min) and was signi cantly reduced in the infarcted SHR/NHsd rats (infarct: 316 6 21 beats/min vs sham: 361 6 8 beats/min) ( Fig 5) .
Magnetic resonance imaging
Infarcted animals showed signi cantly increased left ventricular end diastolic volumes (LVEDV), more in the SHR/NHsd rats (SHR/NHsd infarct: 1522.8 6 21.9 mm 3 vs SHR/NHsd sham: 930.0 6 21.9 mm 3 ) than in the WKY/NHsd rats (WKY/NHsd infarct: 1498.8 6 92.8 mm 3 vs WKY/NHsd sham: 1176.6 6 46.2 mm 3 ) (Fig 6) . However the ejection fraction (EF) was also signi cantly increased in the infarcted SHR/NHsd rats (SHR/NHsd infarct: 18.9 6 2.8% vs SHR/NHsd sham: 45.6 6 4.1%), more than in the infarcted WKY/NHsd animals (WKY/NHsd infarct: 24.5 6 4.2% vs WKY/NHsd sham: 31.5 6 4.2%) (Fig 7) . Figure 8 shows MR images of an infarcted and a sham SHR/NHsd rat in systole and diastole in situ. The infarcted SH rat shows enlarged right and left ventricular chambers, hypertrophy of the septum and reduced left ventricular wall size, as well as uid accumulation in the thoracic cavity.
Lung histology
Lung histology sections showed no signicant alterations in the WKY/NHsd rats. In the SHR/NHsd rats, lungs stained with HE showed signs of acute and/or chronic lung congestion with septal thickening, and macrophages loaded with siderine could be identi ed (Fig 9) .
Organ weight
Lung weight was signi cantly increased in the infarcted rats, more in the SHR/NHsd rats (infarct: 558.8 6 48.4 mg/100 g body weight vs sham: 364.2 6 5.3 mg/100 g body weight) than in the WKY/NHsd rats (infarct: 444.4 6 87.0 mg/100 g body weight vs sham: 334.0 6 9.1 mg/100 g body weight). Total heart weight was also increased in MI, including increases of left and even more right ventricles, more in the SHR/NHsd rats (infarct: 430.7 6 10.8 mg/ 100 g body weight vs sham: 366.3 6 12.7 mg/ 100 g body weight) than in the WKY/ NHsd rats (infarct: 302.8 6 11.6 mg/100 g body weight vs sham: 248.5 6 9.5 mg/ 100 g bw).
Hydroxyproline/proline ratio Hydroxyproline/proline ratio was increased in the infarcted animals, more in the SHR/ NHsd rats (infarct: 0.41 6 0.03 AUC vs sham: 0.17 6 0.02 AUC ) than in the WKY/NHsd rats (infarct: 0.29 6 0.01 AUC vs sham: 0.14 6 0.01 AUC) and more in the SHR/NHsd sham than in the WKY/NHsd sham (SHR/ NHsd sham: 0.17 6 0.02 AUC vs WKY/ NHsd sham: 0.14 6 0.01 AUC).
Clinical signs
The infarcted SHR/NHsd rats showed clinical signs that are seen in severe heart failure patients (NYHA III-IV): dyspnoea, orthopnoea, impaired motion, pale-bluish limbs and subcutaneous oedema.
Discussion
Heart failure is one of the most common causes of death in Western countries. The aim of this study was the establishment and validation of a model of heart failure in the rat, because common models do not always result in parameters and symptoms that extrapolate to the clinical situation of patients with end-stage heart failure. Myocardial infarction causes loss of left ventricular mass and induces replacement by brous tissue and additional reactive brosis. The loss of heart mass is compensated congestion (Nelson et al. 1983 ). Zaumseil and Kersten (1975) described the optimal dosage for maximum diuresis. Survival was also enhanced by closing the thoracic cavity at the maximum inspiration, thereby avoiding pneumothorax. This was also seen by Ye et al. (1997) .
The remodelling process leads to hypertrophy and brosis, resulting in impaired heart function and reduced contractility. Decompensated heart failure results in minor blood ow to the peripheral organs, and minor blood ow back to the heart, and precedes to congestion. As seen here, the contractility or dP/dt max was signi cantly diminished in the infarcted animals. dP/dt was enhanced in the SHR/NHsd sham by comparison with the Wistar sham animals, because the animals had to overcome a permanent enhanced blood pressure which resulted in hypertrophy. This had initial positive effects and enhanced contractility (Bing et al. 1988 ), but later on contractility was diminished (Bing et al. 1988) . In infarcted animals, the renin-angiotensinaldosterone system (RAAS) enhances afterload, and the LV had to enforce more pressure to introduce ejection volume. This results in a lowering of the ejection fraction and enhances the blood remaining in the left ventricle. As predicted by the Frank-Starling principle, this leads to an increase of the ejection fraction in the healthy heart, but results in diminished ejection fraction and contractility in the decompensated heart.
The aortic ow index was also diminished in the infarcted hearts. This was statistically signi cant only in the SH rats. This indicates a similar low-output failure, also seen in other groups (Schoemaker et al. 1991) . This was underlined by the impaired ejection fraction, signi cantly in infarcted SHR/NHsd rats, seen by non-invasive sequential measurements using the MRI technique. Diminished aortic ow leads to a diminished coronary ow which results in reduced oxygen supply to the heart. Additionally the oxygen diffusion distance is increased due to hypertrophy and brosis. This leads to a further worsening of heart energy metabolism and an accumulation of metabolites (lactate) because of anaerobic conditions. Furthermore, delay in clearing anaerobic metabolites further exacerbates damage to the heart muscle (metabolic acidosis) (Kalkman et al. 1996) .
LVEDV was signi cantly enhanced in the infarcted animals, more so in the SHR/NHsd rats. In comparison to the WKY/NHsd sham animals, LVEDV was enhanced in the SHR/NHsd sham animals, indicating the enhanced venous tone and reabsorption of sodium and extravascular uid. This was underlined by other authors who have done LVEDV evaluations in SHR/NHsd and normotensive WKY/NHsd rats without MI (Wise et al. 1998) . Systolic dysfunction was also detected by circumference measurements, indicating enhanced systolic heart sizes. Heart frequency was also diminished in the infarcted SHR/NHsd rats, indicating continued activation of the sympathetic nervous system with down regulation of ß1-receptors (Brodde et al. 1986 , Bristow et al. 1988 ) and increased activation of Giprotein (Bristow et al. 1982 , Fowler et al. 1986 ). Inhibition of adenyl cyclase results in a reduction of intracellular calcium depletion and leads further to impaired contractility, because of emptied cardiac noradrenalin reserves (Hasking et al. 1986 , Davis et al. 1988 . Plasma catecholamines lead to a further increase of after load, because there is no down regulation in the vessels (Forster et al. 1989 , Frey et al. 1989 .
Cardiac decompensation is con rmed through a fall in blood pressure seen in the infarcted animals. There was a larger fall in pressure in the SHR/NHsd group.
Increased right and left ventricular weights indicating hypertrophy of the heart in infarcted and also SH sham animals, due to activation of the RAAS, was also observed by other authors (Bing et al. 1995) . The increase in right ventricular weight, in particular, is an expression of the cor pulmonale (Bing et al. 1995 ) and lung congestion, as shown by the increased lung weight in the infarcted animals. The increase of the hydroxyproline/proline ratio in the infarcted animals and also in the SHR/NHsd sham in comparison to the normotensive WKY/NHsd sham was due to the brosis of the left ventricle in hypertrophied and infarcted myocardium. Enhanced hydroxyprolin/proline ratios in infarcted rats have also been observed by other authors (Linz et al. 1995) .
We were able to establish a new and predictive model of heart failure in the SH rat 8 weeks after coronary artery ligation which shows characteristic parameters and symptoms that can be extrapolated to the clinical situation of patients with end-stage heart failure (NYHA III-IV). Our future aim is to nd new concepts for the causal therapy of heart failure treatment. This model is a valuable method for the early testing of new therapeutic approaches in patients with congestive heart failure.
